Skip to content

Rightsign

by HangZhou Biotest Biotech Co., Ltd. China EUDAMED

Ref MOPGG-LC43

EMDN W0102069006

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-MOPGG-LC43M2 Basic UDI-DIDate19 Aug 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
PG I / PG II/G17 Combo Quantitative Rapid Test (Microfluidic Fluorescent Immunoassay)
Model / Reference
MOPGG-LC43
Primary DI / UDI-DI
D-MOPGG-LC43M2
Basic UDI-DI
B-MOPGG-LC43M2
EMDN Code
W0102069006 Pepsinogen
Device Class
Class IVD General
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
CN-MF-000008191
Authorised representative
RIOMAVIX SOCIEDAD LIMITADA ES-AR-000001202

Properties & raw data

Show properties, registry sources and raw records
  • Reagent
  • Professional Testing
Other properties (9)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (1)

  • EUDAMED b14c5684-c27a-4a3d-9676-b3d6ea73318d 61 fields · synced 24 Oct 2026